*  Cetrorelix (Professional Patient Advice) - Drugs.com
gonadotropin-releasing hormone antagonists Firmagon, degarelix, Cetrotide, ganirelix. Ovulation Induction Clomid, clomiphene, ... Gonadotropin Releasing Hormone Antagonist. Pharmacology. Competes with naturally-occurring GnRH for binding on receptors of the ... Hypersensitivity to cetrorelix, extrinsic peptide hormones, gonadotropin releasing hormone (GnRH) or GnRH analogs, or any ... This delays luteinizing hormone surge, preventing ovulation until the follicles are of adequate size. ...
  https://www.drugs.com/ppa/cetrorelix.html
*  Cetrorelix Acetate For Injection Lyophilised - Cetrorelix Acetate For Injection Lyophilised Manufacturer & Supplier, Bengaluru,...
Gonadotropin- releasing hormone (GnRH) antagonist. *Excellent composition. .formbglight { background-color: #FFFDF4; } . ... In addition, this Cetrorelix Acetate For Injection Lyophilised is also used for delaying luteinizing hormone surges and ...
  http://www.injectionmanufacturer.com/cetrorelix-acetate-for-injection-lyophilised-3303826.html
*  Cetrorelix - Wikipedia
... antagonist. A synthetic decapeptide, it is used is used in assisted reproduction to inhibit premature luteinizing hormone ... and follicle-stimulating hormone (FSH). In addition, cetrorelix can be used to treat hormone-sensitive cancers of the prostate[ ... Gonadotropin-releasing hormone receptor § Antagonists http://www.emdserono.com/ms.country.us/en/images/Cetrotide_PI_tcm115_ ... As an alternative to the GnRH antagonist, also a GnRH agonist could be given, but agonist have to be started earlier to ...
  https://en.wikipedia.org/wiki/Cetrorelix
*  Hormone antagonist - Wikipedia
For the use of hormone antagonists in cancer, see hormonal therapy (oncology) A hormone antagonist is a specific type of ... Hormone antagonists at the US National Library of Medicine Medical Subject Headings (MeSH). ... receptor antagonist which acts upon hormone receptors. Such pharmaceutical drugs are used in antihormone therapy. ...
  https://en.wikipedia.org/wiki/Hormone_antagonist
*  Gonadotropin-releasing hormone antagonist - Wikipedia
Gonadotropin-releasing hormone antagonists (GnRH antagonists) are a class of medications that antagonize the gonadotropin- ... clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat. Clin. Pract. Endocrinol. Metab.: 3: 157 ... GnRH antagonists are also being investigated in the treatment of women with hormone-sensitive breast cancer and some benign ... Degarelix is a GnRH antagonist that is approved for use in patients with advanced hormone-sensitive prostate cancer throughout ...
  https://en.wikipedia.org/wiki/Gonadotropin-releasing_hormone_antagonist
*  Corticotropin-releasing hormone antagonist - Wikipedia
A Corticotropin-Releasing Hormone Antagonist (CRH antagonist) is a specific type of receptor antagonist that blocks the ... Zoumakis E, Rice KC, Gold PW, Chrousos GP (November 2006). "Potential uses of corticotropin-releasing hormone antagonists". ... The main research into clinical CRF antagonists has focused on antagonists selective for the CRF-1 subtype, which is expressed ... a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing ...
  https://en.wikipedia.org/wiki/Corticotropin-releasing_hormone_antagonist
*  XO Korea/business deployment/51180000 Hormones and hormone antagonists - OLPC
XO Korea/business deployment/51180000 Hormones and hormone antagonists. From OLPC. , XO Korea , business deployment ... XO Korea/business deployment/51000000 Drugs and Pharmaceutical Products/51180000 Hormones and hormone antagonists/51181500 ... XO Korea/business deployment/51000000 Drugs and Pharmaceutical Products/51180000 Hormones and hormone antagonists/51181500 ... XO Korea/business deployment/51000000 Drugs and Pharmaceutical Products/51180000 Hormones and hormone antagonists/51181500 ...
  http://wiki.laptop.org/go/XO_Korea/business_deployment/51180000_Hormones_and_hormone_antagonists
*  Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive
... antagonist alone (n = 5) and those that 750 micrograms/kg.day antagonist plus T (n = 5) were azoospermic. After 16 weeks, four ... We examined the effects of the GnRH antagonist Deterelix [N-Ac-DNal(2)1-DpCl-Phe2-DTrp3-DhArg(Et2)6 -DAla10-GnRH], alone and ... We tested the hypothesis that the combination of a GnRH antagonist plus T would suppress spermatogenesis in the male primate to ... Castrate range T levels were achieved in animals receiving antagonist alone. T levels in the groups that received T ...
  https://digital.lib.washington.edu/researchworks/handle/1773/4428
*  Antidiuretic Hormone Antagonist to Reduce Cystine Stone Formation | Annals of Internal Medicine | American College of Physicians
Antidiuretic Hormone Antagonist to Reduce Cystine Stone Formation Hans de Boer, MD, PhD; Anita Roelofsen, MD; Pim M.W. Janssens ... Antidiuretic Hormone Antagonist to Reduce Cystine Stone Formation. Ann Intern Med. 2012;157:459-460. doi: 10.7326/0003-4819-157 ...
  http://annals.org/aim/article-abstract/1359234/antidiuretic-hormone-antagonist-reduce-cystine-stone-formation
*  Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action | Science
Administration of a potent gonadotropin-releasing hormone (GnRH) antagonist [Nac-L-Ala1,pCl-D-Phe2,D-Trp3,6]GnRH as a single ... The prolonged in vivo inhibition of pituitary GnRH receptor binding and luteinizing hormone secretion by the GnRH antagonist ... Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action ... Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action ...
  http://science.sciencemag.org/content/216/4544/420
*  Profound Pituitary Suppression Following Oral Contraceptive Pretreatment in Gonadotropin-releasing Hormone Antagonist Cycles...
2004) Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. ... Oral contraceptive pill; Gonadotropin-releasing hormone; Antagonist; Pituitary suppression; Luteinizing hormone; in vitro ... Both GnRH agonist and antagonist protocols are commonly used for IVF cycles. Compared with gonadotropin-releasing hormone (GnRH ... Profound Pituitary Suppression Following Oral Contraceptive Pretreatment in Gonadotropin-releasing Hormone Antagonist Cycles ...
  https://www.omicsonline.org/open-access/profound-pituitary-suppression-following-oral-contraceptive-pretreatment-in-gonadotropinreleasing-hormone-antagonist-cycles-does-n-2375-4508-1000200.php?aid=88682
*  Research programme: growth hormone antagonists - Asterion/Ipsen - AdisInsight
... antagonists for the potential use in the treatment of acromegaly. ... collaborating on the development of analogues of growth hormone ... Research programme: growth hormone antagonists - Asterion/Ipsen Latest Information Update: 04 Nov 2017 ... Mechanism of Action Somatotropin receptor antagonists * Orphan Drug Status Orphan designation is assigned by a regulatory body ...
  https://adisinsight.springer.com/drugs/800025680?error=cookies_not_supported&code=947ee00c-39fd-4789-b93d-30265fbfb6bf
*  Hormone Antagonists -Pipeline Insights, 2015 | Global Market Research Reports
... provides the in-depth analysis of the pipeline assets across the Hormone Antagonists. The main objective of this report to ... Hormone Antagonists Overview. • Hormone Antagonists Disease Associated. • Hormone Antagonists Pipeline Therapeutics. • Hormone ... Hormone Antagonists Assessment by Stage and Route of Administration • Hormone Antagonists Assessment by Molecule Type • Hormone ... Hormone Antagonists Assessment by Stage and Route of Administration • Hormone Antagonists Assessment by Molecule Type • Hormone ...
  http://www.gosreports.com/hormone-antagonists-pipeline-insights-2015/
*  ICD-10 Diagnosis Code T38.901A Poisoning by unsp hormone antagonists, accidental, init
Poisoning by unsp hormone antagonists, accidental, init Long Description: Poisoning by unspecified hormone antagonists, ... Hormones and their synthetic substitutes and antag, NEC (T38). *T38.901A - Poisoning by unsp hormone antagonists, accidental, ... Hormones Hormones are your body's chemical messengers. They travel in your bloodstream to tissues or organs. They work slowly, ... That is why too much or too little of a certain hormone can be serious. Laboratory tests can measure the hormone levels in your ...
  https://icdlist.com/icd-10/t38901a
*  EP 1028690 A2 20000823 - LUTEINISING HORMONE ANTAGONISTS USEFUL FOR TREATMENT OF ESTROGEN DEFICIENCIES, OR AS A CONTRACEPTIVE
LUTEINISING HORMONE ANTAGONISTS USEFUL FOR TREATMENT OF ESTROGEN DEFICIENCIES, OR AS A CONTRACEPTIVE - [origin: WO9920223A2] A ... A pharmaceutical composition comprising an LH antagonist or a pharmaceutically acceptable salt thereof, and a pharmaceutically ... pharmaceutical composition comprising an LH antagonist or a pharmaceutically acceptable salt thereof, and a pharmaceutically ... LUTEINISING HORMONE ANTAGONISTS USEFUL FOR TREATMENT OF ESTROGEN DEFICIENCIES, OR AS A CONTRACEPTIVE ...
  https://data.epo.org/gpi/EP1028690A2-LUTEINISING-HORMONE-ANTAGONISTS-USEFUL-FOR-TREATMENT-OF-ESTROGEN-DEFICIENCIES-OR-AS-A-CONTRACEPTIVE
*  A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin...
... laboratory and ultrasonographic parameters of a pituitary adenoma secreting follicle-stimulating hormone associated with ... Treatment with gonadotropin-releasing hormone antagonist improved the clinical, ... treatment using a gonadotropin-releasing hormone antagonist. Treatment with gonadotropin-releasing hormone antagonist improved ... associated with ovarian hyperstimulation who was treated with a gonadotropin-releasing hormone (GnRH) antagonist. ...
  https://www.fertstertdialog.com/posts/7160-a-pituitary-adenoma-secreting-follicle-stimulating-hormone-with-ovarian-hyperstimulation-treatment-using-a-gonadotropin-releasing-hormone-antagonist
*  A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin...
Treatment with gonadotropin-releasing hormone antagonist improved the clinical, laboratory and ultrasonographic parameters of a ... treatment using a gonadotropin-releasing hormone antagonist. Posted by carlaasrm on Monday, June 4, 2012 · Leave a Comment ... associated with ovarian hyperstimulation who was treated with a gonadotropin-releasing hormone (GnRH) antagonist. ... The GnRH antagonist was found to be effective for the short-term treatment of ovarian hyperstimulation secondary to a pituitary ...
  http://fertstertforum.com/201297231garmes/
*  Discovery and development of non-peptide antagonists of peptide hormone receptors | Biochemical Society Transactions
Discovery and development of non-peptide antagonists of peptide hormone receptors. D. J. Pettibone, R. M. Freidinger ... Discovery and development of non-peptide antagonists of peptide hormone receptors Message Subject (Your Name) has forwarded a ...
  http://www.biochemsoctrans.org/content/25/3/1051
*  Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone...
2002) T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 438: ... 2002) Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8: 825 ... ABBREVIATIONS: MCH, melanin-concentrating hormone; MCHR, MCH receptor; ACTH, adrenocorticotropic hormone; CRF, corticotropin- ... Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists. Shigeyuki Chaki, Takeo Funakoshi, Shiho ...
  http://jpet.aspetjournals.org/content/313/2/831.long
*  Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma |...
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma. Zoltan ... Kineman R. D. Antitumorigenic actions of growth hormone-releasing hormone antagonists. Proc. Natl. Acad. Sci. USA, 97: 532-534 ... Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma ... Kiaris H., Schally A. V., Varga J. L. Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human ...
  http://cancerres.aacrjournals.org/content/63/22/7913
*  Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein...
Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein ... Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein ... Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein ... Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein ...
  http://jpet.aspetjournals.org/content/274/3/1456
*  Discovery and Characterization of Aminopiperidinecoumarin Melanin Concentrating Hormone Receptor 1 Antagonists
Close The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser. ...
  https://www.infona.pl/resource/bwmeta1.element.acs-doi-10_1021_jm050598r
*  Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist -Pipeline Insight, 2018
Antagonist. The report assesses the active Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist pipeline ... Antagonist. • Features the Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist pipeline across the ... Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist -Pipeline Insight, 2018. *January 2018 • ... "Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2018" report by DelveInsight ...
  https://www.reportbuyer.com/product/5129607/gonadotropin-releasing-hormone-gnrh-receptor-lhrh-receptor-antagonist-pipeline-insight-2018.html
*  Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist - Thaiendocrine.org
Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist. 7 August 2017. 31 October 2017. ... Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist. J Clin Endocrinol Metab 2005 90 ... Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist ... Context: Pegvisomant is a GH receptor antagonist that blocksthe peripheral actions of GH in acromegaly. Pegvisomant, incontrast ...
  http://www.thaiendocrine.org/en/2017/08/07/cotreatment-of-acromegaly-with-a-somatostatin-analog-and-a-growth-hormone-receptor-antagonist/